![]() ![]() Ocriplasmin - variable efficacy? Graefes Arch Clin Exp Ophthalmol 2016 254 (7): 1245–1246. Intravitreal sulfur hexafluoride injection for the treatment of vitreomacular traction syndrome. With VMT, you will have visual symptoms, which may include: Distorted vision (wavy lines) Blurred central vision Reduced vision where small details are more difficult to distinguish Symptomatic VMA is not normally associated with any eye pain, so it is important to share your symptoms with Dr. Am J Ophthalmol 2013 155 (2): 270–6 e2.ĭay S, Martinez JA, Nixon PA, Levitan M, Dooner JW, Wong RW et al. Intravitreal injection of expansile perfluoropropane (c(3)f(8)) for the treatment of vitreomacular traction. Rodrigues IA, Stangos AN, McHugh DA, Jackson TL. Pneumatic retinopexy for the management of impending macular hole: an optical coherence tomography study. Treatment of stage 2 macular hole by intravitreous injection of expansile gas and induction of posterior vitreous detachment. Optical coherence tomography evaluation of idiopathic macular hole treatment by gas-assisted posterior vitreous detachment. How is VMT diagnosed A careful retinal examination can. Jorge R, Costa RA, Cardillo JA, Uno F, Bonomo PP, Farah ME et al. VMT only occurs when there is an abnormally tight adhesion between the shrinking gel and the macula. Intravitreal expansile gas in the treatment of early macular hole: reappraisal. N Engl J Med 2012 367 (7): 606–615.Ĭosta RA, Cardillo JA, Morales PH, Jorge R, Uno F, Farah ME. Retinal Vein oclussions:When the veins in the retina become blocked,blood and fluid then leak out into the macula. In some cases the pulling (traction) remains mild and does not significantly. Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. In VMT the vitreous pulls on the macula and starts to stretch and split the retina. Pneumatic release of focal vitreomacular traction. Treatment of idiopathic macular holes by induced posterior vitreous detachment. Safety and complications of ocriplasmin: ocriplasmin, ocriplasmin oh, how safe art thou? JAMA Ophthalmol 2014 132 (4): 379–380.Ĭhan CK, Wessels IF, Friedrichsen EJ. ![]() Real world outcomes of ocriplasmin use by members of the British and Eire Association of Vitreoretinal Surgeons. ![]()
0 Comments
Leave a Reply. |